MAP kinases in lung endothelial permeability induced by microtubule disassembly

Anna A Birukova1, Konstantin G Birukov, Boris Gorshkov

  • 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, MFL Center Tower, Baltimore, MD 21224, USA.

Insights

p38 MAPK activation directly links microtubule disassembly to lung endothelial cell barrier dysfunction. Inhibiting p38 MAPK prevents barrier failure, suggesting it as a therapeutic target.

Area of Science:

  • Cell Biology
  • Physiology
  • Biochemistry

Background:

  • Lung endothelial barrier integrity is crucial for respiratory health.
  • Microtubule (MT) disassembly contributes to endothelial cell (EC) barrier failure.
  • Mitogen-activated protein kinases (MAPK), including ERK1/2 and p38, regulate cellular processes.

Purpose of the Study:

  • To investigate the role of ERK1/2 and p38 MAPK in lung EC barrier dysfunction caused by MT disassembly.
  • To elucidate the signaling pathways connecting MT dynamics to EC barrier regulation.

Main Methods:

  • Human and bovine pulmonary EC were treated with MT inhibitors (nocodazole, vinblastine).
  • MAPK activation was assessed using phosphospecific antibodies and in vitro assays.
  • EC permeability was measured by transendothelial electrical resistance.
  • Cytoskeletal remodeling was analyzed morphometrically.
  • Pharmacological inhibitors of p38 MAPK (SB-203580) and ERK1/2 (U0126) were used.

Main Results:

  • MT inhibitors induced sustained activation of ERK1/2 and p38 MAPK cascades.
  • This activation correlated with increased EC permeability and cytoskeletal remodeling.
  • MT stabilization partially reduced MAPK activation.
  • Selective p38 MAPK inhibition, but not ERK1/2 inhibition, attenuated MT depolymerization, actin remodeling, and barrier dysfunction.

Conclusions:

  • p38 MAPK activation is a key mediator of MT disassembly-induced lung EC barrier dysfunction.
  • The p38 MAPK pathway plays a critical role in regulating MT network dynamics and EC barrier function.
  • Targeting p38 MAPK may offer a therapeutic strategy for conditions involving lung endothelial barrier failure.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...